Technological watch

US compounder opens second plant / Site selected for proximity to Boston pharma, biotech hotbeds

US compounder opens second plant / Site selected for proximity to Boston pharma, biotech hotbedsThe second compounding facility is expected to ease pressure on the companyâ??s original factory (Photo: Otech)Otech (Rolling Prairie, Indiana; said it has set up a second plant in the East Coast city Auburn, Massachusetts, where it is preparing to install three extrusion lines.
The site is about an hour from Boston, which is considered Americaâ??s most important centre for biotechnology and pharmaceutical developments, with 500 companies in these areas alone. The compounder is likely to build another mainstay with this branch in addition to its main plant near the carmaking hub of Detroit.
The company, managed by Jason Page and Ted Irvine since October 2022, has its roots in PVC compounding, and PVC blends are still Otech's core business, but the company is increasingly turning its attention to thermoplastic elastomers and other products, including conductive and black materials.
Related: French packaging producer enters North American market
Otech operates eleven extrusion lines at its almost 25,000 m² main plant. The current total capacity was quoted at around 55,000 t/y, but after the most recent expansions in 2022, especially for PVC compounds, it is likely around 80,000 t/y. With the three additional lines, another 15,000 tons per year could be added.
In 2019, Otech sold its colour formulation activities to focus entirely on compounds.19.01.2023 [251939-0]

Publication date: 19/01/2023



This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.